|
||
|
||
|
||
|
|
View a specific resident by clicking on the program: | |
|
|
![]() 2007-2008 Residency Class |
|
| R#341: Nicole Brogden, Pharm.D. | ||
| R#342: Russ Judd, Pharm.D. | ||
| R#343: Rachel Stratman, Pharm.D. | ||
| R#344: Lisa Thompson, Pharm.D. | ||
| R#345: Ann Wiesner, Pharm.D. | ||
| R#346: Scott Wirth, Pharm.D. | ||
|
|
||
| R#333: Mark Cox, Pharm.D. | ||
| R#331: Katie Mieure, Pharm.D. | |
|
| R#337: Will Vincent, Pharm.D. | R#338: Emily Borders, Pharm.D. | |
|
|
R#340: Bojana Stevich, Pharm.D. | |
| R#332: Veena Venugopalan, Pharm.D. |
|
|
|
|
R#331: April Anderson, Pharm.D. | |
| R#329: Sommer Zarbock, Pharm.D. | R#339: Julia Ho, Pharm.D. | |
|
|
||
|
||
|
|
|||
| Nicole Brogden, Pharm.D. (R# 341) | |||
|
Dr.
Brogden, originally from Boone, IA, received her Bachelor of Science degree
in Biology in May 2003 and her Doctor of Pharmacy degree in May 2007 from
the University of Iowa in Iowa City, Iowa. During her time at the
University of Iowa, Dr. Brogden was actively involved in benchtop research
in the Microbiology and Medicinal and Natural Products Chemistry
Departments. In addition to her residency clinical responsibilities, Dr.
Brogden is a member of the Kentucky Konnection and Grand Rounds
Committees, and is also actively involved with the University of Kentucky
College of Pharmacy, serving as a preceptor for fourth-year pharmacy
students on clinical rotations as well as a small group discussion
facilitator. Dr. Brogden plans to complete The Scholarship of Teaching
and Learning Certificate Program. Her research project involves an
evaluation of the short-term effects of linezolid on mean FEV1
during an acute exacerbation of cystic fibrosis in patients with positive
methicillin-resistant S. aureus (MRSA) sputum cultures. Upon
completing her PGY1 pharmacy residency, she plans to complete a Ph.D.
program in clinical and translational sciences. Ultimately, Dr. Brogden
plans to pursue a position that combines research and academia. E-mail: nkbrog2@email.uky.edu |
|
||
|
|||
| Russ Judd, Pharm.D. (R# 342) | |||
|
Dr. Judd, originally from Greensburg, Kentucky, received his Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 2007. In addition to his clinical responsibilities, Dr. Judd is a member of the Residency Recruitment and Grand Rounds Committees. He is also actively involved with the University of Kentucky College of Pharmacy serving as a preceptor for fourth-year pharmacy students on clinical rotations as well as a small group discussion facilitator. Dr. Judd has a strong interest in teaching and plans to complete The Scholarship of Teaching and Learning Certificate Program. He is currently investigating the impact of stress ulcer prophylaxis in low-risk patients and the continuation of these medications at hospital discharge. Upon completion of his PGY1 residency, Dr. Judd plans to complete a specialized residency in infectious diseases at the University of Kentucky. Ultimately, he hopes to obtain a position at an academic medical center with clinical and academic responsibilities.
E-mail: wrjudd2@email.uky.edu |
|
||
|
|||
| Rachel Stratman, Pharm.D. (R# 343) | |||
|
Dr. Stratman, originally from Argyle, MO, received her Bachelor of Pharmacy degree in August 2004 and her Doctor of Pharmacy degree in 2005 from the St. Louis College of Pharmacy. In addition to clinical responsibilities, she is a member of the Kentucky Konnection and the Residency Computer Committee. Further, she is actively involved in teaching activities through the University of Kentucky College of Pharmacy including precepting fourth year students on rotations, facilitating small group discussions, and providing lectures. Dr. Stratman is also working toward completion of the Scholarship of Teaching and Learning Certificate program to enhance her teaching skills. Her research activities focus on evaluating bleeding events in patients receiving recombinant human activated protein C. Dr. Stratman plans to complete a specialized residency in critical care at the University of Kentucky. Ultimately, she hopes to obtain a position at an academic medical center that integrates clinical responsibilities, research, and academia.
E-mail: rcstra2@email.uky.edu |
|
||
|
|||
| Lisa Thompson, Pharm.D. (R#344) | |||
|
Dr. Thompson, originally from Philpot, KY, received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in May 2007. In addition to her clinical responsibilities, Dr. Thompson is a member of the Grand Rounds and Social Committees. She is also actively involved with the University of Kentucky College of Pharmacy by precepting fourth-year pharmacy students on clinical rotations and by facilitating small group discussions. Dr. Thompson plans to complete The Scholarship of Teaching and Learning Certificate Program. She is currently investigating the calciuneurin inhibitor-sparing effects of basiliximab induction therapy in liver transplant recipients. Upon finishing her PGY1 pharmacy residency, she plans to complete a PGY2 residency. Ultimately, Dr. Thompson plans to pursue a position that combines both academia and clinical services.
|
|
||
|
|||
| Ann Wiesner, Pharm.D. (R#345) | |||
|
Dr. Wiesner, originally from Maryville, TN, received her Doctor of Pharmacy degree from the University of South Carolina College of Pharmacy in 2007. Her current practice interests include pediatrics, ambulatory care, and infectious disease. In addition to her clinical responsibilities, Dr. Wiesner serves on the Residency Recruitment and Computer committees. She is also actively involved at the College of Pharmacy by precepting fourth-year students on clinical rotations, facilitating small group discussions, and serving on the Service and Nominations committee. To help develop her teaching skills, she plans to complete the Scholarship of Teaching and Learning Certificate program. Dr. Wiesner is currently investigating the role of pharmacists in public health via conduction of a national survey to assess pharmacy services in free medical clinics. Upon finishing her PGY1 residency, she plans to complete a PGY2 residency in one of her areas of interest. Ultimately, Dr. Wiesner hopes to obtain a position that combines both academia and clinical services and is considering pursuing graduate studies in public health.
E-mail: amwies2@email.uky.edu |
|
||
|
|||
| Scott Wirth, Pharm.D. (R#346) | |||
|
Dr. Wirth, originally from Albany, Illinois, received his Doctor of Pharmacy degree In May of 2007 from the University of Illinois at Chicago College of Pharmacy in Chicago, Illinois. In addition to his clinical responsibilities, Dr. Wirth is a member of the Residency Social and Residency Recruitment Committees. He is also actively involved with the University of Kentucky College of Pharmacy serving as a preceptor for fourth-year pharmacy students on clinical rotations as well as a small group discussion facilitator. Further, Dr. Wirth has a strong interest in teaching and plans to complete The Scholarship of Teaching and Learning Certificate Program. He is currently investigating the incidence, diagnosis, and management of heparin-induced thrombocytopenia at the University of Kentucky. His current practice interests include critical care and hematology/oncology. Upon completion of his PGY1 residency, Dr. Wirth plans to complete a specialized residency at the University of Kentucky. Ultimately, he hopes to obtain a position at an academic medical center that combines academia, research, and clinical responsibilities.
E-mail: smwirt2@email.uky.edu |
|
||
|
|||
|
|
|||
|
|
|||
| Mark Cox, Pharm.D. (R#333) | |||
|
Dr. Cox, originally from Tempe, Arizona, received his Doctor of Pharmacy degree in December 2005 from the College of Pharmacy at the University of Montana, Missoula. He completed his PGY1 residency at the University of Kentucky this past July, and is now a PGY2 resident in critical care. In addition to his clinical responsibilities, Dr. Cox is actively engaged in teaching, research, and service relating to pharmacy. He is a preceptor for fourth-year pharmacy students, and serves as an instructor and small group facilitator for the University's College of Pharmacy. He is also a member of two teaching-related committees: the Pharmacy Practice Department Curriculum Committee and the Honors and Awards Committee. Because of his strong interest in teaching, Dr. Cox plans to complete The Scholarship of Teaching and Learning Certificate. Dr. Cox recently completed one research project, and is currently engaged in a second project. His completed research investigated the rate of antimicrobial de-escalation based on microbiological data, and he is presently studying the outcomes of critically ill patients colonized with multidrug-resistant organisms. Finally, Dr. Cox serves on two residency program committees: the Social Committee and the Computer Committee. Upon completing his residency, Dr. Cox would like to obtain a position that allows him to integrate clinical pharmacy practice with teaching and research.
E-mail: mrcox3@email.uky.edu |
|
||
|
|||
| Katie Mieure, Pharm.D. (R#331) | |||
|
Dr. Mieure, originally from Roseville, MN, received her Doctor of Pharmacy degree from Drake University in 2006, and completed a Postgraduate Year One Pharmacy Residency at the University of Kentucky in 2007. She is currently a Postgraduate Year Two Critical Care Specialty Resident and serves as Chief Resident. In addition to clinical responsibilities, she is involved in teaching activities through the College of Pharmacy including precepting fourth year students on rotations, facilitating small group discussions, providing lectures, and serving on the Residency Committee. She is also working toward completion of the Scholarship of Teaching and Learning Certificate program to enhance her teaching skills. Dr. Mieure’s research activities focus on surveillance cultures predicting clinical cultures in adult intensive care unit patients. Upon completion of residency training, she hopes to obtain a position at a teaching institution that integrates academia and delivery of clinical pharmacy services.
E-mail:kdmieu2@email.uky.edu |
|
||
|
|||
| Will Vincent, Pharm.D. (R# 337) | |||
|
Dr. Vincent, originally from Bridgewater, NJ, received his Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey. In addition to clinical responsibilities, Dr. Vincent serves on the Residency Social, Recruitment, and Kentucky Konnection Committees. Dr. Vincent is also actively involved with the University of Kentucky College of Pharmacy assisting in the precepting of fourth-year pharmacy students on clinical rotations, serving as an instructor for small group discussions, and participating in the curriculum committee. He has a strong interest in teaching and plans to complete The Scholarship of Teaching and Learning Certificate Program. Dr. Vincent recently completed an investigation of the effects of pharmacist-to-dose computerized requests on promptness of antimicrobial therapy. He is now studying antibiotic utilization in critically ill patients colonized with multi-drug resistant organisms. Additionally, he volunteers at the University of Kentucky Student-Run Free Clinic at the Salvation Army and HIV/AIDS Clinic and recently traveled to Haiti on a medical mission trip. Dr. Vincent completed his PGY1 residency and is now a PGY2 resident in critical care at the University of Kentucky. In the future, Dr. Vincent would like to pursue graduate studies in public health.
E-mail: wrvinc2@email.uky.edu |
|
||
|
|||
|
|
|||
|
|
|||
| Veena Venugopalan, Pharm.D. (R# 332) | |||
|
Dr. Venugopalan, originally from Lusaka, Zambia, received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 2006. Dr. Venugopalan completed her pharmacy practice residency at the University of Kentucky and is currently the PGY2 infectious diseases Resident. Her current practice interests include antibiotic resistance and HIV. In addition to her clinical responsibilities, Dr. Venugopalan serves as Chair of the Kentucky Konnection and the Pharmacy Grand Rounds Committees. She is also actively involved with the University of Kentucky College of Pharmacy serving as a preceptor for fourth-year pharmacy students on clinical rotations as well as a small group discussion facilitator. Dr. Venugopalan has a keen interest in teaching and she plans to complete The Scholarship of Teaching and Learning Certificate Program. She is currently investigating the failure in treatment of Staphylococcus aureus isolates with increased MICs to vancomycin. Ultimately, Dr. Venugopalan plans to pursue a position that combines both academia and clinical services.
E-mail: vvenu1@email.uky.edu |
|
||
|
|||
|
|||
|
|
|||
| Sommer Zarbock, Pharm.D. (R# 329) | |||
|
Dr. Zarbock, originally from Fort Morgan, CO, received her Bachelor of Science degree in double majors of Chemistry and Soil and Crop Sciences with a minor in Microbiology in May 2002 from Colorado State University and her Doctor of Pharmacy degree from University of Colorado School of Pharmacy in 2006. Dr. Zarbock completed her Postgraduate Year One (PGY1) residency at the University of Kentucky HealthCare and is currently a Postgraduate Year Two (PGY2) specialty resident in Adult Internal Medicine. In addition to her clinical responsibilities, Dr. Zarbock is a member of the School of Pharmacy Curriculum, Recruitment and Grand Rounds Committees and is the Pharmacy Resident On-Call Chair. Further, she is actively involved with the University of Kentucky College of Pharmacy serving as a preceptor for fourth-year pharmacy students on clinical rotations as well as a small group discussion facilitator. Dr. Zarbock also has a strong interest in teaching and plans to complete The Scholarship of Teaching and Learning Certificate Program. She is currently investigating the outcomes associated with drug eluting stent placement based on outcome insurance to determine the rates of stent thrombosis in patients with early termination of clopidogrel therapy. Ultimately, Dr. Zarbock plans to pursue a position that combines academia, clinical, and research responsibilities.
E-mail: sdzarb3@email.uky.edu |
|
||
|
|
|||
|
|||
|
|
|||
|
|
|||
| Emily Borders, Pharm.D. (R# 338) | |||
|
Dr. Borders, originally from Fort Smith, AR, received her Doctor of Pharmacy degree from The University of Oklahoma College of Pharmacy in 2006. Dr. Borders completed her pharmacy practice residency at the University of Oklahoma before coming to the University of Kentucky as a PGY2 hematology/oncology resident. In addition to clinical responsibilities, she is involved in residency committees such as the Residency Social committee and the Kentucky Konnection committee. Dr. Borders has a strong interest in teaching and enjoys precepting fourth-year students on rotation and facilitating small group discussions at the College of Pharmacy. She also plans to complete the Scholarship of Teaching and Learning Certificate program. Dr. Borders’ research efforts will focus on determining response rates in patients with metastatic colorectal cancer who have received treatment with oxaliplatin and calcium and magnesium infusions. In the future, Dr. Borders hopes to obtain a position that combines research with academic and clinical responsibilities.
E-mail: ebbord2@email.uky.edu |
|
||
|
|||
| Bojana Stevich, Pharm.D. (R# 340) | |||
|
Dr. Stevich was born in Zagreb, Croatia. She received Bachelor of Science in Biology and Chemistry (magna cum laude, 1997-2000) and Master of Science in Molecular Biology with thesis on DNA replication (2002) form Youngstown State University. Dr. Stevich received Doctor of Pharmacy degree from Lake Erie College of Osteopathic Medicine School of Pharmacy (2006) and completed Pharmacy Practice Residency at the University of Tennessee (2007). She is currently pursuing Oncology Pharmacy Residency. Dr. Stevich serves on Resident Recruitment and Kentucky Connection committees at the University of Kentucky Medical Center Department of Pharmacy. She precepts 4th year pharmacy students on clinical rotations, gives didactic lectures in oncology and teaches oncology labs at the University of Kentucky College of Pharmacy. She is a member of Curriculum committee at the UK College of Pharmacy and is completing Scholarship of Teaching and Learning Certificate program. Dr. Stevich’s research interests include oncology drug development preclinical and Phase I studies, fidelity of DNA replication, mechanisms of DNA repair and pharmacogenetics. Dr. Stevich is a member of ACCP, ASHP, HOPA and National Honors Key Society.
E-mail: bstev3@email.uky.edu |
|
||
|
|||
|
|
|||
|
|||
|
|
|||
| April Anderson, Pharm.D. (R# 331) | |||
|
Email: alande3@email.uky.edu |
|
||
|
|||
| Julia Ho, Pharm.D. (R#339) | |||
|
Dr. Ho is originally from Hong Kong, China and received her Doctor of Pharmacy degree in August 2000 from the University of Kentucky College of Pharmacy. After graduation, she practiced as a clinical staff pharmacist at the University of Kentucky HealthCare for seven years. During that time, she was engaged in providing clinical services in a variety of areas such as pediatrics, oncology, operating room and central operation. She served as a pharmacy-nursing liaison for the Newborn Nursery, Obstetrics and Labor & Delivery units. She also assisted in the implementation of standardized drip concentrations and pyxis dispensing system in the Kentucky Children’s Hospital. She was the recipient of the UK Hospital Core Value Award for Accountability in March 2007. She is currently a Pediatric Specialty Resident at the University of Kentucky HealthCare. Dr. Ho’s research project is centered on the evaluation of targeted beta-lactam continuous infusion antibiotics on FEV1 for an acute pulmonary exacerbation in Cystic Fibrosis patients. Upon completion of her pediatric residency, she would like to pursue a position that focuses on clinical practice and academia.
E-mail: pmho11@email.uky.edu |
|
||
|
|
|||
|
|||
UK
Healthcare Pharmacy Services
College of Pharmacy
University of Kentucky
Contact us |
|||